QA: Organogenesis Holdings Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001661181_2019_Organogenesis_Holdings_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}

Graph

Absolute values for 0001661181, Organogenesis Holdings Inc

  xvar xval
0 AssetsCurrent 71,131,000
1 IntangibleAssetsNetIncludingGoodwill 51,630,000
2 PropertyPlantAndEquipmentNet 39,623,000
3 remainder_Assets 1,294,000
4 LiabilitiesCurrent 66,388,000
5 LiabilitiesNoncurrent 903,000
6 remainder_Liabilities 49,346,000
7 CostOfGoodsAndServicesSold 68,808,000
8 SellingGeneralAndAdministrativeExpense 161,961,000
9 ResearchAndDevelopmentExpense 10,742,000
10 remainder_Expenses 3,578,000
11 remainder_Revenues 193,449,000
12 remainder_NetIncome -13,191,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 163,678,000
1 Liabilities 116,637,000
2 Expenses 245,089,000
3 Revenues 193,449,000
4 StockholdersEquity 47,041,000
5 NetIncome -64,831,000
6 ComprehensiveNetIncome -64,831,000
7 BaseVar 366,022,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.269
9 EconomicCapitalRatio 1.67

Edgar->Model Mapping

Feature Distribution